Additiv fremstilling

Lægemiddeludvikling med bioelektroniske scaffolds – En anden anvendelse af 3D‑printning

mm
Udgivet den
Opdateret den
Føj Securities.io til dine foretrukne kilder på Google
Oplysning: Securities.io kan modtage betaling, når du bruger links til produkter, vi anmelder. Det påvirker ikke vores redaktionelle vurderinger. Vi er ikke registreret investeringsrådgiver; dette er ikke investeringsrådgivning. Læs vores affiliateoplysning.

The additive manufacturing sector continues to show near-limitless potential. Innovations have taken 3D printers from creating customized figurines all the way to printing entire neighborhoods, working electronics, and even human organs. Now, researchers at Washington University in St. Louis have developed a novel method for 3D‑printing bioelectronic scaffolds designed to support tissue formation. While this technology does not yet enable the direct printing of fully functional organs, it represents a significant step toward improving engineered tissue for medical applications.

Traditionelle metoder til vævsudvikling

Most people are unaware that tissue development is a crucial process of drug testing and other vital medical practices. Researchers will use natural or artificially created scaffolds that support a variety of cells, including primary cells, stem cells, and immortalized cell lines, to create living tissue for drug testing and other purposes.

Blodceller

Blodceller


mm

David Hamilton er en fuldtidsjournalist og en længerevarende bitcoinist. Han specialiserer sig i at skrive artikler om blockchain. Hans artikler er blevet offentliggjort i flere bitcoin-publikationer, herunder Bitcoinlightning.com